Navamedic ASA: Q4 2022 financial results
Oslo, 16 February 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces its results for the fourth quarter of 2022. In the period, Navamedic delivered another quarter with solid growth across its portfolio, resulting in a 29 per cent increase in revenues to NOK 116.0 million compared to the same...
Taggar: navamedic, financial, results
Läs hela artikeln på Dagens industri